ABOUT ARCHEOPTIX

ArcheOptix Biomedical, Inc. is a privately-held, medical device company that has developed technologies to rapidly and accurately assess the severity of Traumatic Brain Injury (TBI). Our unique and novel approach to Near Infrared Spectroscopy (NIRS), has allowed us to take an old idea and create something that is now medically viable. By introducing motion to NIRS, we offer a revolutionary advance on previous technologies’ ability to detect and image intra-cranial bleeds. Our devices are non-invasive, non-ionizing, portable and very easy to use. The assessment procedure takes 1 – 3 minutes. Our devices will allow for the rapid and accurate assessment as to the severity of TBI, helping the person at the point of injury determine the need for an immediate CT scan. ArcheOptix Biomedical Inc. is an ISO-certified company (ISO 13485:2016 and has obtained MDSAP certification).

ArcheOptix’s mission is to develop and commercialize new technologies to improve outcomes from Traumatic Brain Injury (TBI).

OUR TEAM